Contera Pharma identifies and develops innovative treatments for patients suffering from neurological disorders. Contera Pharma’s science is based on a precision medicine approach integrating external and internal data sources to support rational ID & selection of human disease-validated drug discovery targets to identify novel pipeline opportunities.
The company uses expertise in neuroscience drug discovery and development, in close collaboration with expert individuals and organizations, to accelerate R&D activities.